Glycogen storage disease type IV
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Glycogen storage disease type IV | ||
Glycogen | ||
ICD-10 | E74.0 | |
ICD-9 | 271.0 | |
OMIM | 232500 | |
DiseasesDB | 5303 | |
MeSH | C16.320.565.202.449.540 |
; Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]
Synonyms and keywords: Glycogenosis type IV , Andersen's disease , glycogen branching enzyme deficiency (GBED , polyglucosan body disease, amylopectinosis
Glycogen storage disease type IV is a very rare hereditary metabolic disorder.
Human pathology
It is a result of the absence of the glycogen branching enzyme amylo-1,4-1,6 transglucosidase, which is critical in the production of glycogen. This leads to very long unbranched glucose chains being stored in glycogen. The long unbranched molecules (known as amylopectin) have a low solubility which leads to glycogen precipitation in the liver. These deposits subsequently build up in the body tissue, especially the heart and liver. The end result is liver failure and eventual death occurring in the first year of life.